Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV-positive Oropharyngeal Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT03215719
What this trial is testing

Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma

Who this might be right for
Oropharyngeal CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
NYU Langone Health 120
Not applicableLooking for participantsNCT03875716
What this trial is testing

Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 111
Testing effectiveness (Phase 2)Looking for participantsNCT05136196
What this trial is testing

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT03226613
What this trial is testing

New Modalities for Detection of Oropharyngeal Cancer

Who this might be right for
Human Papillomavirus Positive Oropharyngeal Squamous Cell CarcinomaOropharynx CancerBase of Tongue Carcinoma+1 more
Vanderbilt University Medical Center 51
Not applicableStudy completedNCT02147418
What this trial is testing

Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oropharyngeal Cancer
New Mexico Cancer Research Alliance 15
Testing effectiveness (Phase 2)Looking for participantsNCT06323460
What this trial is testing

Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Oropharyngeal Squamous Cell Carcinoma
Ohio State University Comprehensive Cancer Center 45
Not applicableEnded earlyNCT05061940
What this trial is testing

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

Who this might be right for
Head and Neck CancerMelanomaHPV-Related Malignancy+5 more
Repertoire Immune Medicines 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03224000
What this trial is testing

Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer

Who this might be right for
Malignant Neoplasms of Lip Oral Cavity and PharynxOropharyngeal Cancer
M.D. Anderson Cancer Center 90
Not applicableActive Not RecruitingNCT04965792
What this trial is testing

Post-treatment Surveillance in HPV+ Oropharyngeal SCC

Who this might be right for
HPVOropharyngeal Squamous Cell Carcinoma
Dana-Farber Cancer Institute 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT04920344
What this trial is testing

Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+1 more
Rutgers, The State University of New Jersey
Testing effectiveness (Phase 2)Ended earlyNCT02706691
What this trial is testing

BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer

Who this might be right for
FGFR Gene AmplificationFGFR1 Gene AmplificationFGFR2 Gene Amplification+7 more
University of Chicago 1
Testing effectiveness (Phase 2)Study completedNCT02048020
What this trial is testing

Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer

Who this might be right for
Human Papilloma Virus InfectionStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the Larynx+13 more
Jonsson Comprehensive Cancer Center 26
Large-scale testing (Phase 3)UnknownNCT01855451
What this trial is testing

Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Trans Tasman Radiation Oncology Group 189
Not applicableLooking for participantsNCT05918510
What this trial is testing

Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus

Who this might be right for
Squamous Cell Carcinoma of the OropharynxCarcinomas of Unknown Primary SiteHigh-risk Human Papillomavirus Infection+3 more
Regina Elena Cancer Institute 142
Not applicableNot Yet RecruitingNCT07797738
What this trial is testing

Prognostic Biomarkers for Patients With Human Papillomavirus (HPV) Positive Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (OPSCC)HPVHPV Positive Oropharyngeal Squamous Cell Carcinoma
Abramson Cancer Center at Penn Medicine 30
Testing effectiveness (Phase 2)Looking for participantsNCT06636734
What this trial is testing

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown PrimaryMetastatic Head and Neck Squamous Cell Carcinoma+19 more
Emory University
Early research (Phase 1)Ended earlyNCT04301011
What this trial is testing

Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors

Who this might be right for
Solid TumorMicrosatellite Stable Colorectal CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+6 more
Turnstone Biologics, Corp. 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT05714657
What this trial is testing

Shortened Course Adjuvant Radiotherapy Following TORS

Who this might be right for
HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Abramson Cancer Center at Penn Medicine 104
Early research (Phase 1)Study completedNCT02113878
What this trial is testing

Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckHPV Positive Oropharyngeal Squamous Cell CarcinomaHypopharyngeal Cancer+3 more
Dana-Farber Cancer Institute 23
Not applicableStudy completedNCT02072148
What this trial is testing

The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)

Who this might be right for
Human Papilloma VirusOropharyngeal Squamous Cell Carcinoma
Icahn School of Medicine at Mount Sinai 112
Next Page
150
15
28